Latest News about AMGN
Recent news which mentions AMGN
Healthcare Stocks Subject to Government Policy
November 02, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Here are the five dumbest ways you could have gotten rich in 2021
November 02, 2021
From MarketWatch
Mirati Therapeutics COO, CMO Exit, Completing Management Overhaul
November 01, 2021
From Benzinga
CNBC's Final Trades: Amgen, Marriot And Mastercard
November 01, 2021
From Benzinga
Carter Worth Says This Stock Is 'So Bad That It Is Good'
November 01, 2021
Tickers
AMGN
From Benzinga
From MarketWatch
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
These 8 money-losing stocks could bring you big gains come January
October 26, 2021
From MarketWatch
Tech will dominate this week, but here’s one up-and-coming sector investors shouldn’t overlook
October 25, 2021
From MarketWatch
Danielle Shay Expects This Dow Laggard To Hit New Highs
October 22, 2021
From Benzinga
From Benzinga
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
From Benzinga
From Benzinga
From Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
From Motley Fool
Got $5,000? 3 Top Dividend Stocks to Buy Right Now
October 13, 2021
From Motley Fool
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
3 High-Yielding Dividend Stocks Trading Near Their 52-Week Lows
October 08, 2021
From Motley Fool
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
Amgen Highlights Lumakras Combination Data From Solid Tumor Trials
October 07, 2021
Tickers
AMGN
From Benzinga
3 Dividend-Paying Nasdaq 100 Stocks to Buy Hand Over Fist in October
October 07, 2021
From Motley Fool
From Benzinga
Amgen, Neumora Collaborate On Precision Therapies for Brain Diseases
October 07, 2021
Tickers
AMGN
From Benzinga
2 Ridiculously Cheap Growth Stocks to Buy
October 02, 2021
From Motley Fool
More than a quarter of Nasdaq-100 stocks are in bear markets — Wall Street sees a buying opportunity
September 29, 2021
From MarketWatch
Only 47 stocks in the S&P 500 have fallen over the past year — Wall Street predicts they will climb up to 54% in 12 months
September 28, 2021
From MarketWatch
Better Buy: Amgen or All 30 Dow Jones Stocks?
September 28, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.